380 related articles for article (PubMed ID: 14658972)
1. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
[TBL] [Abstract][Full Text] [Related]
2. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine.
Shen J; Chung SA; Kayumov L; Moller H; Hossain N; Wang X; Deb P; Sun F; Huang X; Novak M; Appleton D; Shapiro CM
Can J Psychiatry; 2006 Jan; 51(1):27-34. PubMed ID: 16491981
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.
Winokur A; Sateia MJ; Hayes JB; Bayles-Dazet W; MacDonald MM; Gary KA
Biol Psychiatry; 2000 Jul; 48(1):75-8. PubMed ID: 10913511
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
6. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
[TBL] [Abstract][Full Text] [Related]
8. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
9. Effect of mirtazapine versus fluoxetine on "sleep quality".
Lawrence RW
J Clin Psychiatry; 2004 Aug; 65(8):1149-50. PubMed ID: 15323610
[No Abstract] [Full Text] [Related]
10. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Benkert O; Szegedi A; Philipp M; Kohnen R; Heinrich C; Heukels A; van der Vegte-Senden M; Baker RA; Simmons JH; Schutte AJ
J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.
Shen J; Moller HJ; Wang X; Chung SA; Shapiro GK; Li X; Shapiro CM
J Clin Psychiatry; 2009 Mar; 70(3):370-7. PubMed ID: 19192466
[TBL] [Abstract][Full Text] [Related]
12. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression.
Kim SW; Shin IS; Kim JM; Kim YC; Kim KS; Kim KM; Yang SJ; Yoon JS
Psychiatry Clin Neurosci; 2008 Feb; 62(1):75-83. PubMed ID: 18289144
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
Brown MC; Nimmerrichter AA; Guest JF
Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352
[TBL] [Abstract][Full Text] [Related]
15. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
19. Effects of mirtazapine on sleep polygraphic variables in major depression.
Schittecatte M; Dumont F; Machowski R; Cornil C; Lavergne F; Wilmotte J
Neuropsychobiology; 2002; 46(4):197-201. PubMed ID: 12566938
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
